Low efficacy adenosine A1 agonists inhibit striatal acetylcholine release in rats improving central selectivity of action

Neuroscience Letters

Volumn 343, Issue 1, 2003, Pages 57-61

  Bueters, Tjerk J H ^a,b   Van Helden, Herman P M ^a   IJzerman, Adriaan P ^b   Danhof, Meindert ^b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Acetylcholine; Adenosine; Adenosine A1 receptor; Low efficacy agonist; Microdialysis; Tissue selectivity

Indexed keywords

2' DEOXY 6 N CYCLOPENTYLADENOSINE; 3' DEOXY 6 N CYCLOPENTYLADENOSINE; 6 N CYCLOPENTYLADENOSINE; 8 BUTYLAMINO 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYLTHEOPHYLLINE; 8 ETHYLAMINO 6 N CYCLOPENTYLADENOSINE; ACETYLCHOLINE; ADENOSINE A1 RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0038075555     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00311-2     Document Type: Article

References (16)

1. 1 receptor allosteric modulators PD 81,723 and LUF 5484 on the striatal acetylcholine release. Eur. J. Pharmacol. 454:2002;177-182.
2. Damsma G., Westerink B.H., De Vries J.B., Van den Berg C.J., Horn A.S. Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis. J. Neurochem. 48:1987;1523-1528.
3. Dunwiddie T.V., Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24:2001;31-55.
4. Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:2001;527-552.
5. IJzerman A.P., Vander Wenden E.M., Von Frijtag Drabbe Kunzel J.K., Mathot R.A., Danhof M., Borea P.A., Varani K. Partial agonism of theophylline-7-riboside on adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;638-645.
6. Kirkpatrick K.A., Richardson P.J. Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes. Br. J. Pharmacol. 110:1993;949-954.
7. 2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes. Br. J. Pharmacol. 136:2002;434-440.
8. Materi L.M., Rasmusson D.D., Semba K. Inhibition of synaptically evoked cortical acetylcholine release by adenosine: an in vivo microdialysis study in the rat. Neuroscience. 97:2000;219-226.
9. Moor E., Schirm E., Jacso J., Westerink B.H. Effects of neostigmine and atropine on basal and handling-induced acetylcholine output from ventral hippocampus. Neuroscience. 82:1998;819-825.
10. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol. 321:1997;181-188.
11. Pedata F., Giovannelli L., De Sarno P., Pepeu G. Effect of adenosine, adenosine derivatives, and caffeine on acetylcholine release from brain synaptosomes: interaction with muscarinic autoregulatory mechanisms. J. Neurochem. 46:1986;1593-1598.
12. 1 receptors. J. Med. Chem. 39:1996;1463-1471.
13. 1 receptor agonists in rats: prediction of tissue-dependent efficacy in vivo. J. Pharmacol. Exp. Ther. 290:1999;702-709.
14. Van der Wenden E.M., Von Frijtag Drabbe Kunzel J.K., Mathot R.A., Danhof M., IJzerman A.P., Soudijn W. Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. J. Med. Chem. 38:1995;4000-4006.
15. Van Helden H.P., Bueters T.J. Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning. Trends Pharmacol. Sci. 20:1999;438-441.
16. 6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats. Br. J. Pharmacol. 124:1998;607-618.